These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20846522)

  • 81. The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease.
    Lee JI; Kim MC; Moon BS; Song YS; Han EN; Lee HS; Son Y; Kim J; Han EJ; Park HJ; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Endocrinol Metab (Seoul); 2016 Mar; 31(1):86-92. PubMed ID: 26754585
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
    Morrison MC; Kleemann R
    Front Immunol; 2015; 6():308. PubMed ID: 26124760
    [TBL] [Abstract][Full Text] [Related]  

  • 83. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.
    Puchner SB; Lu MT; Mayrhofer T; Liu T; Pursnani A; Ghoshhajra BB; Truong QA; Wiviott SD; Fleg JL; Hoffmann U; Ferencik M
    Radiology; 2015 Mar; 274(3):693-701. PubMed ID: 25369449
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Moderate oxidative stress and high antioxidative activity are associated with steatosis in Japanese males.
    Imatoh T; Kamimura S; Tanihara S
    Clin Transl Sci; 2013 Feb; 6(1):45-9. PubMed ID: 23399089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?
    Tarantino G; Finelli C; Colao A; Capone D; Tarantino M; Grimaldi E; Chianese D; Gioia S; Pasanisi F; Contaldo F; Scopacasa F; Savastano S
    J Transl Med; 2012 Mar; 10():50. PubMed ID: 22424154
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.
    Chiang CH; Huang PH; Chung FP; Chen ZY; Leu HB; Huang CC; Wu TC; Chen JW; Lin SJ
    PLoS One; 2012; 7(2):e31799. PubMed ID: 22359630
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.
    Lampon N; Tutor JC
    Ups J Med Sci; 2011 May; 116(2):148-54. PubMed ID: 21190397
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease.
    Targher G
    J Hepatol; 2006 Dec; 45(6):879-81; author reply 881-2. PubMed ID: 17049665
    [No Abstract]   [Full Text] [Related]  

  • 91. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.
    Chiang CH; Huang CC; Chan WL; Chen JW; Leu HB
    Clin Biochem; 2010 Dec; 43(18):1399-404. PubMed ID: 20846522
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.